Related Experiment Video
Updated: May 9, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells
Lynette J Schedlich1, Vanessa M Yenson, Robert C Baxter
1Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, Sydney, NSW 2065, Australia. lyn.schedlich@sydney.edu.au
Abstract:
Signaling pathways initiated by transforming growth factor-β (TGF-β) and insulin-like growth factors (IGFs) are important in osteosarcoma cell growth. We have investigated a role for endogenous IGF binding protein-3 (IGFBP-3) in mediating cross-talk between TGF-β receptor and type I IGF receptor (IGF1R) signaling pathways in MG-63 osteosarcoma cells. TGF-β1 indirectly activated the Ras/Raf/MAPK pathway and induced the expression of IGFBP-3, an important regulator of IGF1R activity. IGFBP-3 attenuated TGF-β1 activation of ERK1/2 and Akt in MG-63 cells, and inhibited TGF-β1-induced cell cycle progression and proliferation. This effect of IGFBP-3 was blocked by inhibiting IGF1R signaling. TGF-β1 phosphorylated Smad2 on the non-receptor substrate sites (Ser245/250/255). Blocking the TGF-β1-induced expression of IGFBP-3 enhanced pSmad2(Ser245/250/255) and increased its nuclear accumulation. These results suggest an important role for TGF-β1 in osteosarcoma cell growth, with the induction of IGFBP-3 by TGF-β1 serving in a negative-feedback loop to control cell growth by preventing activation of the IGF1R.
Insights
Transforming growth factor-β (TGF-β) signaling induces insulin-like growth factor binding protein-3 (IGFBP-3) in osteosarcoma cells. This IGFBP-3 then inhibits cell growth by negatively regulating the type I IGF receptor (IGF1R) pathway.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Research
Background:
- Transforming growth factor-β (TGF-β) and insulin-like growth factors (IGFs) signaling pathways are crucial in osteosarcoma cell proliferation.
- Understanding the cross-talk between these pathways is vital for developing targeted therapies.
Purpose of the Study:
- To investigate the role of endogenous insulin-like growth factor binding protein-3 (IGFBP-3) in mediating cross-talk between TGF-β receptor and type I IGF receptor (IGF1R) signaling in MG-63 osteosarcoma cells.
- To elucidate the regulatory mechanisms governing osteosarcoma cell growth.
Main Methods:
- Utilized MG-63 osteosarcoma cell line.
- Investigated the activation of Ras/Raf/MAPK pathway and expression of IGFBP-3.
- Assessed the effects of IGFBP-3 on ERK1/2 and Akt activation.
- Examined the impact of IGFBP-3 on cell cycle progression and proliferation.
- Analyzed Smad2 phosphorylation and nuclear accumulation.
Main Results:
- TGF-β1 indirectly activated the Ras/Raf/MAPK pathway and induced IGFBP-3 expression.
- IGFBP-3 attenuated TGF-β1-induced activation of ERK1/2 and Akt, inhibiting cell cycle progression and proliferation.
- Inhibition of IGF1R signaling blocked the effects of IGFBP-3.
- Blocking TGF-β1-induced IGFBP-3 expression enhanced Smad2 phosphorylation and nuclear accumulation.
Conclusions:
- TGF-β1 plays a significant role in osteosarcoma cell growth.
- TGF-β1-induced IGFBP-3 acts as a negative-feedback mechanism to control cell growth.
- This feedback loop functions by preventing the activation of the IGF1R pathway, thereby regulating osteosarcoma proliferation.
Related Concept Videos
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
